Trials / Completed
CompletedNCT03849612
A Study of an Automated Insulin Delivery System in Adult Participants With Type 1 Diabetes Mellitus
An Early Feasibility Study to Evaluate Basal Initialization Parameters in an Automated Insulin Delivery System in Adult Patients With Type 1 Diabetes Mellitus
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- Eli Lilly and Company · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate whether an Automated Insulin Delivery (AID) System is safe to use and functions as intended with personalized basal insulin rates and when basal insulin rates are increased.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | AID System | AID system |
| DRUG | Insulin Lispro | Individualized doses of insulin lispro administered via the AID system to maintain glycemic control, except during procedures designed to induce hyperglycemia and hypoglycemia. |
Timeline
- Start date
- 2019-02-21
- Primary completion
- 2019-03-27
- Completion
- 2019-03-27
- First posted
- 2019-02-21
- Last updated
- 2019-04-25
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03849612. Inclusion in this directory is not an endorsement.